DocGo Inc. Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price
DocGo Inc. (DCGO) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price of $0.00 per share for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-17.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice · last filed 2026-08-17
- DocGo Inc. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2026-03-31 was $0.00.
- DocGo Inc. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2025-03-31 was $0.00, a 100.00% decline year-over-year.
- DocGo Inc. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2024-03-31 was $3.66.
- DocGo Inc. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2022-03-31 was $3.61.
- DocGo Inc. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- DocGo Inc. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2024 was $3.59, a 54.73% decline from fiscal 2023.
- DocGo Inc. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2023 was $7.93, a 12.64% increase from fiscal 2022.
- DocGo Inc. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2022 was $7.04, a 144.44% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 3 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 6 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 9 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-17 | |||
| 2026-03-31 | $0.00 10-Q · filed 2026-05-11 | |||
| 2025-12-31 | $0.00 10-K · filed 2026-03-16 | |||
| 2025-09-30 | $0.00 10-Q · filed 2025-11-10 | |||
| 2025-06-30 | $0.00 10-Q · filed 2025-08-07 | |||
| 2025-03-31 | $0.00 10-Q · filed 2025-05-08 | |||
| 2024-12-31 | $3.59 10-K · filed 2026-03-16 | |||
| 2024-09-30 | $2.54 10-Q · filed 2024-11-07 | |||
| 2024-06-30 | $2.54 10-Q · filed 2024-08-07 | |||
| 2024-03-31 | $3.66 10-Q · filed 2024-05-08 | |||
| 2023-12-31 | $7.93 10-K · filed 2026-03-16 | |||
| 2023-09-30 | $8.92 10-Q · filed 2023-11-06 | |||
| 2023-06-30 | $8.61 10-Q · filed 2023-08-08 | |||
| 2022-12-31 | $7.04 10-K · filed 2024-02-28 | |||
| 2022-09-30 | $5.92 10-Q · filed 2022-11-08 | |||
| 2022-06-30 | $4.67 10-Q · filed 2022-08-09 | |||
| 2022-03-31 | $3.61 10-Q · filed 2022-05-10 | |||
| 2021-12-31 | $2.88 10-K · filed 2023-03-14 | |||
| 2020-12-31 | $1.66 10-K · filed 2022-03-15 | |||
| 2019-12-31 | $1.59 10-K · filed 2022-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |